2010305A19Rik Activators
DDX58 Activators encompass a diverse array of chemical compounds that, while not directly enhancing the transcription or translation of DDX58, modulate cellular pathways which result in the increased activity of the DDX58 protein. Poly(I:C) and 5'-Triphosphate RNA are two such compounds, the former being a synthetic analog of dsRNA and the latter a naturally occurring viral RNA pattern, both of which bind directly to DDX58. The classification of compounds as 2010305A19Rik Activators refers to a group of chemicals that are specifically identified for their ability to increase the expression of the 2010305A19Rik gene. The identification of such activators typically begins with a high-throughput screening (HTS) process, which involves testing vast libraries of chemical compounds to find those that can enhance the activity of the gene.
This gene, encoded in the mouse genome, may play roles in various cellular processes, and understanding how to control its expression is key to elucidating its function. During the screening, compounds are introduced to cell lines engineered to report on the activity of the 2010305A19Rik gene, often through a luminescent or fluorescent reporter system. Compounds that can activate the gene will result in increased reporter signal, which is measured using appropriate detection instruments. Those that lead to a significant increase in signal are considered hits and are selected for further validation. An increase in mRNA levels as observed through qPCR is a strong indication of gene activation at the transcriptional level. Moreover, to assess whether the increased mRNA translates into higher protein production, Western blotting is employed. This technique can detect and quantify the protein product of the 2010305A19Rik gene, providing evidence that the compound's activation effect extends to protein expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC), which is involved in various signaling cascades. PKC activation can result in the phosphorylation of 2010305A19Rik, potentially increasing its activity within its pathway. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate interacts with its G protein-coupled receptors, leading to intracellular signaling events. This can activate downstream kinases that may phosphorylate 2010305A19Rik, thus enhancing its functional activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, activating calcium-dependent protein kinases. These kinases could then activate 2010305A19Rik by phosphorylation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore elevating intracellular Ca2+, which may activate calcium/calmodulin-dependent protein kinases. These kinases can phosphorylate and potentially enhance the activity of 2010305A19Rik. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP. Elevated levels of these cyclic nucleotides could lead to the activation of kinases that enhance 2010305A19Rik activity. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
FTY720 is a sphingosine-1-phosphate receptor modulator, which can lead to downstream kinase activation. These activated kinases may phosphorylate and increase the activity of 2010305A19Rik. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit certain protein kinases, potentially reducing negative regulatory influences on 2010305A19Rik, thereby enhancing its activity by relief of inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can alter downstream signaling pathways. By inhibiting PI3K, it may reduce inhibitory signals, indirectly enhancing the activation of 2010305A19Rik through kinase cascades. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK. By inhibiting p38, it could shift the balance of cellular signaling towards pathways that activate 2010305A19Rik, thereby indirectly enhancing its activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor which may lead to a reduced competitive inhibition for kinases that could activate 2010305A19Rik, potentially increasing the protein's functional activity through phosphorylation. | ||||||